mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.8 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.8 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.8 |